Annovis Stock Based Compensation from 2010 to 2024

ANVS Stock

USD 7.28 0.57 8.49%

Annovis Bio Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation will likely drop to about 3.2 M in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2018-03-31

Previous Quarter

1.6 M

Current Value

2.4 B

Quarterly Volatility

480 M

Covid

Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 3.3 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.

Check out the analysis of Annovis Bio Correlation against competitors.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Annovis Bio over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Annovis Bio's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Annovis Stock Based Compensation Regression Statistics

	Arithmetic Mean	1,602,761
	Geometric Mean	196,758
	Coefficient Of Variation	168.90
	Mean Deviation	2,073,126
	Median	48,495
	Standard Deviation	2,707,002
	Sample Variance	7.3T
	Range	9.1M
	R-Value	0.70
	Mean Square Error	4T
	R-Squared	0.49
	Significance	0
	Slope	425,684
	Total Sum of Squares	102.6T

Annovis Stock Based Compensation History

	2024	3.2 M
	2023	4.6 M
	2022	9.2 M
	2021	4.7 M
	2020	1.9 M
	2019	8483.0
	2018	82.7 K

Other Fundumenentals of Annovis Bio

Stock Based Compensation To Revenue

Annovis Bio Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt	Long Term Debt Total	Deferred Long Term Liab
Total Assets		0.92	0.75	-0.36	0.52	0.21	-0.04	0.99	0.12	-0.15	0.23	-0.15	-0.92	0.7	0.89	0.92	0.67	-0.1	-0.1	-0.1
Total Stockholder Equity	0.92		0.5	-0.03	0.41	0.21	-0.42	0.91	0.24	0.0	0.21	0.02	-0.9	0.43	0.93	0.9	0.49	0.23	0.23	0.23
Net Tangible Assets	0.75	0.5		-0.88	0.34	-0.05	0.45	0.76	-0.24	-0.12	-0.03	-0.21	-0.66	0.98	0.54	0.67	0.9	-0.66	-0.66	-0.66
Retained Earnings	-0.36	-0.03	-0.88		-0.18	0.15	-0.75	-0.37	0.43	0.2	0.15	0.32	0.27	-0.89	-0.12	-0.28	-0.78	0.87	0.87	0.87
Accounts Payable	0.52	0.41	0.34	-0.18		0.82	0.19	0.41	0.69	-0.13	0.85	-0.16	-0.17	0.21	0.16	0.17	0.17	-0.06	-0.06	-0.06
Net Receivables	0.21	0.21	-0.05	0.15	0.82		-0.03	0.09	0.81	-0.2	0.98	-0.22	0.12	-0.19	-0.11	-0.12	-0.19	0.12	0.12	0.12
Total Liab	-0.04	-0.42	0.45	-0.75	0.19	-0.03		-0.04	-0.32	-0.37	0.01	-0.45	0.17	0.5	-0.32	-0.16	0.32	-0.78	-0.78	-0.78
Total Current Assets	0.99	0.91	0.76	-0.37	0.41	0.09	-0.04		0.0	-0.17	0.1	-0.17	-0.96	0.73	0.93	0.96	0.71	-0.09	-0.09	-0.09
Intangible Assets	0.12	0.24	-0.24	0.43	0.69	0.81	-0.32	0.0		0.35	0.87	0.36	0.16	-0.39	-0.1	-0.16	-0.38	0.34	0.34	0.34
Common Stock	-0.15	0.0	-0.12	0.2	-0.13	-0.2	-0.37	-0.17	0.35		-0.11	0.98	0.14	-0.18	-0.12	-0.14	-0.2	0.11	0.11	0.11
Property Plant Equipment	0.23	0.21	-0.03	0.15	0.85	0.98	0.01	0.1	0.87	-0.11		-0.13	0.12	-0.17	-0.1	-0.12	-0.18	0.11	0.11	0.11
Good Will	-0.15	0.02	-0.21	0.32	-0.16	-0.22	-0.45	-0.17	0.36	0.98	-0.13		0.12	-0.26	-0.09	-0.12	-0.29	0.18	0.18	0.18
Net Debt	-0.92	-0.9	-0.66	0.27	-0.17	0.12	0.17	-0.96	0.16	0.14	0.12	0.12		-0.67	-0.98	-1.0	-0.68	-0.01	-0.01	-0.01
Capital Surpluse	0.7	0.43	0.98	-0.89	0.21	-0.19	0.5	0.73	-0.39	-0.18	-0.17	-0.26	-0.67		0.54	0.68	0.92	-0.68	-0.68	-0.68
Net Invested Capital	0.89	0.93	0.54	-0.12	0.16	-0.11	-0.32	0.93	-0.1	-0.12	-0.1	-0.09	-0.98	0.54		0.98	0.6	0.17	0.17	0.17
Net Working Capital	0.92	0.9	0.67	-0.28	0.17	-0.12	-0.16	0.96	-0.16	-0.14	-0.12	-0.12	-1.0	0.68	0.98		0.69	0.01	0.01	0.01
Capital Stock	0.67	0.49	0.9	-0.78	0.17	-0.19	0.32	0.71	-0.38	-0.2	-0.18	-0.29	-0.68	0.92	0.6	0.69		-0.48	-0.48	-0.48
Long Term Debt	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48		1.0	1.0
Long Term Debt Total	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48	1.0		1.0
Deferred Long Term Liab	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48	1.0	1.0

Click cells to compare fundamentals

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Stock Based Compensation	4.6 M	3.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Annovis Stock Based Compensation from 2010 to 2024

Latest Annovis Bio's Stock Based Compensation Growth Pattern

Annovis Stock Based Compensation Regression Statistics

Annovis Stock Based Compensation History

Other Fundumenentals of Annovis Bio

Annovis Bio Stock Based Compensation component correlations

About Annovis Bio Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Annovis Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY